Saibainco tablets 200mg (also known as Cibinqo), manufactured by Pfizer, contain abrocitinib (YJ code: 4490037F3029). This JAK1 inhibitor is approved for the treatment of moderate-to-severe atopic dermatitis, with a recommended dose of 200mg per tablet.
Saibainco tablets 200mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
